The Texas Rangers are making a bold move to bolster their bullpen, and it’s sparking conversations across the baseball world. According to multiple reports Sunday night, the team has inked a one-year, $4 million deal with veteran right-hander Jakob Junis. But here’s where it gets interesting: Junis, who started his career as a starter with the Kansas City Royals in 2017, transitioned exclusively to a bullpen role in 2025 with the Cleveland Guardians. During his lone season in Cleveland, he posted an impressive 4-1 record with a 2.97 ERA, striking out 55 batters while walking just 18 in 66 2/3 innings across 57 games. This performance is a far cry from his career averages, which include a 46-46 record, a 4.36 ERA, and 768 strikeouts over 847 innings with five different teams—the Royals, San Francisco Giants, Milwaukee Brewers, Cincinnati Reds, and Guardians. And this is the part most people miss: Junis was drafted in the 29th round of the 2011 MLB Draft by the Royals, proving that late-round picks can indeed become valuable assets.
The Rangers’ decision to sign Junis comes at a critical time, as their bullpen struggled last season, converting only 56% of save opportunities—one of the worst records in the majors. The team also lost key relievers Phil Maton and Hoby Milner to the Chicago Cubs in free agency. To address these gaps, Texas has been active this offseason, adding lefty Tyler Alexander and right-handers Alexis Diaz, Carter Baumler, and Zak Kent, while re-signing Chris Martin to a one-year, $4 million deal.
But here’s the controversial part: Is Junis the missing piece the Rangers need to turn their bullpen around? While his 2025 performance was stellar, his career numbers suggest inconsistency. Could this be a high-risk, high-reward move, or are the Rangers overestimating his potential impact? Let’s not forget, Cleveland signed him for $4.5 million last year, and now he’s taking a pay cut to join Texas. What does this say about his market value, and is this a smart investment for the Rangers?
This signing raises more questions than answers, and it’s sure to divide opinions among fans and analysts alike. What do you think? Is Jakob Junis the solution to the Rangers’ bullpen woes, or is this a gamble that might not pay off? Share your thoughts in the comments below—we’d love to hear your take!
